Immunisation with gamma globulin to Murray Valley encephalitis virus and with an inactivated Japanese encephalitis virus vaccine as prophylaxis against Australian encephalitis: Evaluation in a mouse model

Journal of Medical Virology

Volumn 61, Issue 2, 2000, Pages 259-265

  Broom, Annette K ^a   Wallace, Margaret J ^a   Mackenzie, John S ^b   Smith, David W ^c   Hall, Roy A ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Enhancement; Protection; Western Australia

Indexed keywords

IMMUNOGLOBULIN; INACTIVATED VACCINE; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; AUSTRALIA; CHILD; CONTROLLED STUDY; ENCEPHALITIS VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PROPHYLAXIS; VIRUS ENCEPHALITIS;

ANIMALS; ANIMALS, SUCKLING; ANTIBODIES, VIRAL; CHILD; DISEASE MODELS, ANIMAL; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS VIRUS, MURRAY VALLEY; ENCEPHALITIS, ARBOVIRUS; GAMMA-GLOBULINS; HUMANS; IMMUNIZATION, PASSIVE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; NEUTRALIZATION TESTS; PLAQUE ASSAY; VACCINATION; VACCINES, INACTIVATED; VIRAL VACCINES;

ANIMALIA; FLAVIVIRUS; JAPANESE ENCEPHALITIS VIRUS; MURRAY VALLEY ENCEPHALITIS VIRUS; RNA VIRUSES;

EID: 0034013235     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(200006)61:2<259::AID-JMV13>3.0.CO;2-M     Document Type: Article

References (30)

1. Barrett ADT, Gould EA. 1986. Antibody-mediated early death in vivo after infection with Yellow Fever virus. J Gen Virol 67:2539-2542.
2. Broom A, Lindsay M, Van Heuzen B, Wright T, Mackenzie J, Smith D. 1997. Contrasting patterns of flavivirus activity in the Kimberley region of Western Australia, 1992-1996. Arbovirus Res Aust 7:25-30.
3. Broom AK, Mackenzie JS, Lindsay MD, Wright AE. 1989. Epidemiology of MVE and Kunjin viruses in Western Australia, 1980-89. Arbovirus Res Aust 5:14-18.
4. Calisher CH, Karabatsos N, Dalrymple JM, Shope RE, Porterfield JS, Westaway EG, Brandt WE. 1989. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol 70:37-43.
5. Colombage G, Hall R, Pavy M, Lobigs M. 1998. DNA-based and alphavirus-vectored immunisation with PrM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virology 250:151-163.
6. De Madrid AT, Porterfield JS. 1974. The flaviviruses (group B arboviruses): a cross-neutralization study. J Gen Virol 23:91-96.
7. Gould EA, Buckley A. 1989. Antibody-dependent enhancement of Yellow Fever and Japanese Encephalitis virus neurovirulence. J Gen Virol 70:1605-1608.
8. Gould EA, Buckley A, Barrett ADT, Cammack N. 1986. Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. J Gen Virol 67:591-596.
9. Hall RA, Brand TNH, Lobigs M, Sangster, MY, Howard MJ, Mackenzie JS. 1996. Protective immune responses to the E and NS1 proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice. J Gen Virol 77:1287-1294.
10. Hall RA, Broom AK, Hartnett AC, Howard MJ, Mackenzie JS. 1995. Immunodominant epitopes on the NS1 protein of Murray Valley encephalitis and Kunjin viruses serve as targets for a blocking ELISA to detect virus specific antibodies in sentinel animal serum. J Virol Methods 51:201-210.
11. Hall RA, Coelen RJ, Mackenzie JS. 1991. Immunoaffinity purification of the NS1 protein of Murray Valley encephalitis virus; selection of the appropriate ligand and optimal conditions for elution. J Virol Methods 32:11-20.
12. Halstead SB. 1982. Immune Enhancement of Viral Infection. Prog Allergy 31:301-364.
13. Halstead SB, O'Rourke EJ. 1977. Dengue viruses and mononuclear phagocytes. 1. Infection enhancement by non-neutralizing antibody. J Exp Med 146:201-217.
14. Halstead SB, Porterfield JS, O'Rourke EJ. 1980. Enhancement of dengue virus infection in monocytes by flavivirus antisera. Am J Trop Med Hyg 29:638-642.
15. Hanna JN, Ritchie SA, Phillips DA, Shield J, Bailey MC, Mackenzie JS, Poidinger M, McCall BJ, Mills PJ. 1996. An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust 165:256-260.
16. Hawkes RA. 1964. Enhancement of the infectivity of arboviruses by specific antisera produced in domestic fowls. Aust J Exp Biol Med Sci 42:465-482.
17. Hawkes RA, Lafferty KJ. 1967. The enhancement of virus infectivity by antibody. Virology 33:250-261.
18. Kluger G, Schottler A, Waldvogel K, Nadal D, Hinrichs W, Wundisch GF, Laub MC. 1995. Tickborne encephalitis despite specific immunoglobulin prophylaxis. Lancet 346:1502.
19. Kreil TR, Eibl MM. 1997. Pre-and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in the mouse model. J Virol 71:2921-2927.
20. Kreil TR, Majer E, Fraiss S, Eibl MM. 1998. Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein. Am Soc Microbiol 72:3076-3081.
21. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
22. Mackenzie JS, Smith DW, Broom AK, Bucens MR. 1993. Australian encephalitis in Western Australia, 1978-1991. Med J Aust 158: 591-595.
23. Mackenzie JS. Broom AK, Hall RA, Johansen CA, Lindsay MD, Phillips DA, Ritchie SA, Russell RC, Smith DW. 1998. Arboviruses in the Australasian region, 1990 to 1998. Commun Dis Intell Aust 22:93-100.
24. McDonagh TJ. 1966. Passive immunization with gamma globulin. Bull NY Acad Med 42:850-861.
25. Morens DM, Halstead SB. 1990. Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies. J Gen Virol 71:2909-2914.
26. Peris JSM, Porterfield JS. 1979. Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines. Nature 282: 509-511.
27. Sangster MY, Urosevic N, Mansfield JP, Mackenzie JS, Shellam GR. 1994. Mapping of the Flv locus controlling resistance to flaviviruses on mouse chromosome 5. J Virol 68:448-452.
28. Schlesinger JJ, Brandriss MW, Walsh EE. 1985. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J Immunol 135:2805-2809.
29. Timofeev AV, Ozherelkov SV, Pronin AV, Deeva AV, Karganova GG, Elbert LB, Stephenson JR. 1998. Immunological basis for protection in a murine model of tick-borne encephalitis by a recombinant adenovirus carrying the gene encoding the NS1 non-structural protein. J Gen Virol 79:689-695.
30. Tsai TF, Chang GJ, Yu YX. 1999. Japanese encephalitis vaccines. In: Plotkin SA, Orenstein WA, editors. Vaccines. Philadelphia: WB Saunders. p 672-710.